Prestige Consumer Healthcare Inc. filed a Form 8-K with the SEC on November 5, 2026, announcing financial results for the fiscal quarter and six months ended September 30, 2026, and disclosing the start of an investor presentation under Regulation FD.

Key Highlights

  • Reporting period: Financial results cover the fiscal quarter and six months ended September 30, 2026.
  • Earnings announcement: The company announced results via a press release dated November 5, 2026, attached as Exhibit 99.1.
  • Investor presentation: Representatives began making presentations to investors on November 5, 2026, using slides attached as Exhibit 99.2.
  • Presentation scope: The company disclosed it expects to use the investor presentation, "in whole or in part, and possibly with modifications," through the fiscal year ended March 31, 2027.
  • Signing officer: The filing was signed by Christine Sacco, Chief Financial Officer and Chief Operating Officer.

Prestige Consumer Healthcare Discloses Q2 FY2027 Results and Investor Slides

Prestige Consumer Healthcare Inc. (NYSE:PBH), headquartered in Tarrytown, New York, filed a current report on November 5, 2026, under Items 2.02 and 7.01, covering results of operations and a Regulation FD disclosure. According to the filing, a press release announcing earnings for the fiscal quarter and six months ended September 30, 2026, was furnished as Exhibit 99.1 and incorporated by reference.

Under Item 7.01, the filing states that company representatives began presenting investor slides on November 5, 2026, using materials attached as Exhibit 99.2. The company disclosed it expects to use the investor presentation, "in whole or in part, and possibly with modifications, in connection with presentations to investors, analysts and others during the fiscal year ended March 31, 2027." The filing also noted that the investor presentation "is summary information that is intended to be considered in the context of the Company's Securities and Exchange Commission filings and other public announcements."

The filing specifies that the information in Items 2.02 and 7.01, along with Exhibits 99.1 and 99.2, is furnished and "shall not be deemed to be 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934." The company stated it undertakes no obligation to publicly update or revise the information, though it may do so as management believes warranted. Christine Sacco, Chief Financial Officer and Chief Operating Officer, signed the filing on behalf of the registrant.

What Was Disclosed

Prestige Consumer Healthcare filed an 8-K on November 5, 2026, furnishing a press release and investor presentation related to fiscal second-quarter and first-half results for the period ended September 30, 2026, without filing those exhibits for Exchange Act liability purposes.